Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Third Dose Of Pfizer, Moderna COVID-19 Vaccines Has Similar Side Effects To Second Dose, CDC Survey Indicates

    The New York Times (9/28, Mueller) reports that “Americans who received a third dose of a coronavirus vaccine in recent weeks reported side effects at roughly the same rates as they had after their second shots, the Centers for Disease Control and Prevent...
    Full Article
  • WHO Aims To Eliminate Bacterial Meningitis By 2030

    Reuters (9/28, Mandhan) reports, “The World Health Organization (WHO) is aiming to eliminate the most deadly form of meningitis by 2030 through increased awareness and access to treatments, global plans launched by the UN-agency on Tuesday to combat the i...
    Full Article
  • Poorly Controlled HIV Possibly Linked To Increased Risk For SCD, Study Suggests

    Infectious Disease Advisor (9/28, Nye) reports, “Individuals with HIV infection who have either increased viral loads or decreased CD4 cell counts may be at an increased risk for sudden cardiac death (SCD), according to results of an observational, longit...
    Full Article
  • Smoking May Be Likely To Increase COVID-19 Severity, Risk For Mortality, Research Indicates

    Healio (9/28, T. Welsh) reports research indicates that “smoking is highly likely to increase COVID-19 severity and associated risk for mortality.” Investigators “performed large-scale observational and Mendelian randomization analyses using data from the...
    Full Article
  • “Mu” SARS-CoV-2 Variant Eradicated In US, Site Says

    Newsweek (9/28, Dutton) reports, “The ‘B.1.621’ or ‘Mu’ variant of COVID-19 that sparked fears of vaccine resistance and increased infectiousness, appears to have been eradicated in the U.S., according to virus tracking website Outbreak.info.” According t...
    Full Article
  • Testing For COVID-19 20% Higher Among Patients With Immune-Mediated Inflammatory Disease, Study Finds

    Healio (9/27, Laday) reports, “Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to” a study. Despite a higher rate of testing, however, “the risk for SARS-CoV-2 infecti...
    Full Article
  • Researchers Say They Have Discovered Group Of Bacterial Species, Strains That May Be Used As An Alternative To FMT To Restore A Patient’s Gut Microbiome

    Healio (9/27, Stonehill) reports investigators have “discovered a group of bacterial species and strains that may be used as an alternative to fecal microbiota transplantation [FMT] to restore a patient’s gut microbiome” after collecting “1,008 bacterial...
    Full Article
  • Researchers Develop 3D-Printed Vaccine Patch

    mHealth Intelligence (9/27, Wicklund) reports, “Researchers are developing an mHealth wearable that might someday take the sting out of vaccine shots and make them more effective as well.” The researchers “developed a 3D-printed vaccine patch that would n...
    Full Article
  • Average Of New COVID-19 Vaccinations At Lowest Level Since January

    CNN (9/27, Holcombe, Waldrop) reports, “The daily pace of new Covid-19 vaccinations in the United States is the lowest it has been since the Centers for Disease Control and Prevention started tracking it in mid-January” at a seven-day average rate of 231,...
    Full Article
  • Pfizer Begins Trial Of mRNA Flu Vaccine

    Reuters (9/27, Mishra) reports that on Monday, Pfizer announced “it had dosed the first patient in a trial testing a flu vaccine based on messenger RNA” that “will test the vaccine in healthy adults ages 65- 85.”
    Full Article
  • Pfizer Starts Mid-To-Late-Stage Study Testing Oral Antiviral For Prevention Of COVID-19 Infection

    Reuters (9/27, Maddipatla, Khandekar, Chandra Eluri) reports that on Monday, Pfizer Inc announced that “it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have...
    Full Article
  • Expert Discusses Disparities Faced By People Living With HIV With Regard To Underutilization Of Statin Therapies

    Healio (9/27, Buzby) reports, “People living with HIV are at elevated CV risk and evidence-based cholesterol lowering therapies are either underutilized or contraindicated based on patients’ anti-retroviral HIV therapies, according to” a presentation give...
    Full Article
  • Parents Hopeful After Pfizer Reports Positive Clinical Trial Data For Its Vaccine In Children Ages 5 To 11

    The Washington Post (9/27, A1, Bever) reports Pfizer-BioNTech last week “reported that clinical trial data showed their vaccine was safe and effective in children ages 5 to 11 – a much-anticipated announcement that left many parents heartened at the prosp...
    Full Article
  • States Begin Complicated COVID-19 Booster Shot Rollout Even As Millions Remain Unvaccinated

    The New York Times (9/24, A1, Weiland, Abelson, Hoffman) reported, “State health officials rushed on Friday to roll out campaigns to provide coronavirus booster shots for millions of vulnerable people who got the Pfizer-BioNTech vaccine and to help a conf...
    Full Article
  • A Start-Up Continues To Charge $380 For A COVID-19 Test

    The New York Times (9/26, A1, Kliff) reports, “At the drugstore, a rapid COVID test usually costs less than $20.” In contrast, “across the country, over a dozen testing sites owned by the start-up company GS Labs regularly bill $380.” This continues becau...
    Full Article
  • Pfizer COVID-19 Vaccine Elicits Lower Antibody Levels In Older Adults Compared To Younger Adults, Research Shows

    Healio (9/24, Downey) reported, “The Pfizer-BioNTech COVID-19 vaccine elicited ‘relatively lower’ antibody levels in adults aged 50 years or older than in adults aged younger than 50 years, researchers reported in JAMA Network Open.” Researchers “conducte...
    Full Article
  • Scientists’ Profiles Of Coronavirus Mutations Help Find Pathogen’s Weak Spots, Ways To Exploit Them

    Bloomberg (9/25, Gale) reported scientists have been profiling the coronavirus and “that information is now revealing the pathogen’s weak spots and ways to exploit them.” Research from “the La Jolla Institute of Immunology led to a study Thursday in Scien...
    Full Article
  • Study Compares Preventive Tuberculosis Therapies In Patients With HIV Infection

    Infectious Disease Advisor (9/24, Heck) reported, “Among individuals with HIV infection currently taking antiretroviral therapy (ART), self-administered preventive tuberculosis (TB) therapy with a 3-month course of rifapentine and isoniazid was found to b...
    Full Article
  • Federal, State Authorities Say US Has Enough COVID-19 Vaccine Doses For Boosters, Kids’ Shots

    The AP (9/26, Richmond, Foody) reports, “US health authorities said they’re confident there will be enough for both qualified older Americans seeking booster shots and the young children for whom initial vaccines are expected to be approved in the not-too...
    Full Article
  • COVID-19 Vaccine Providers Prepare For Booster Shot Distribution

    The Wall Street Journal (9/24, Whelan, Terlep, Subscription Publication) reported that pharmacies and other COVID-19 vaccine providers are preparing for a surge in demand for doses after the CDC’s endorsement of offering boosters to people over 18 with un...
    Full Article
  • «
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id